CGON (CG Oncology) OCF Margin %: -5,257.89% (As of Mar. 2026)


CGON CG Oncology Inc CGON
12 GF Score
Price $71.96
! 6 Warning Signs
View Full Analysis

What is CG Oncology OCF Margin %?

CG Oncology CGON -1.22% 12 OCF Margin % is -5,257.89% as of Mar. 2026. GuruFocus rates CGON with a GF Score™ of 12/100. The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, CG Oncology ranks worse than 87.07% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. CG Oncology's Cash Flow from Operations for the three months ended in Mar. 2026 was $-56.94 Mil. CG Oncology's Revenue for the three months ended in Mar. 2026 was $1.08 Mil. Therefore, CG Oncology's OCF Margin % for the quarter that ended in Mar. 2026 was -5,257.89%.

As of today, CG Oncology's current OCF Yield % is -2.52%.

The historical rank and industry rank for CG Oncology's OCF Margin % or its related term are showing as below:

CGON' s OCF Margin % Range Over the Past 10 Years
Min: -22391.67   Med: -6910.71   Max: -131.82
Current: -3155.43

During the past 5 years, the highest OCF Margin % of CG Oncology was -131.82%. The lowest was -22391.67%. And the median was -6910.71%.

CGON's OCF Margin % is ranked worse than
87.07% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs CGON: -3155.43

CG Oncology OCF Margin % Related Terms

CG Oncology OCF Margin % Historical Data

* Premium members only.

The historical data trend for CG Oncology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CG Oncology OCF Margin % Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
-131.82 -15,604.19 -22,391.67 -6,910.71 -3,275.89

CG Oncology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -56,301.92 0.00 -2,334.57 -1,559.69 -5,257.89

CGON vs CRSP, XENE, TGTX: OCF Margin % Comparison

For the Biotechnology subindustry, CG Oncology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CG Oncology OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CG Oncology's OCF Margin % distribution charts can be found below:

* The bar in red indicates where CG Oncology's OCF Margin % falls into.


CGON
12GF Score
CG Oncology Inc CGON
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CG Oncology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

CG Oncology's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-132.346/4.04
=-3,275.89 %

CG Oncology's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-56.943/1.083
=-5,257.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -5,257.89% mean?
CG Oncology (CGON) has a OCF Margin % of -5,257.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CG Oncology and its competitors. According to the industry distribution chart, CG Oncology ranks #835 out of 959 companies in the Biotechnology industry, placing it in the top 87.1%.
Is CG Oncology's OCF Margin % too high?
CG Oncology's current OCF Margin % is -5,257.89%. Based on the distribution chart, CG Oncology ranks #835 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CG Oncology has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CG Oncology's OCF Margin % compare to CRSP and XENE?
According to the Biotechnology industry distribution chart, CG Oncology ranks #835 out of 959 companies for OCF Margin %. This places CG Oncology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CG Oncology and its competitors. CG Oncology's current OCF Margin % is -5,257.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CG Oncology stock overvalued right now?
CG Oncology (CGON) has a current OCF Margin % of -5,257.89%. The current OCF Margin % is -5,257.89%. CG Oncology's overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CG Oncology (CGON), the current OCF Margin % is -5,257.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CG Oncology Business Description

Address 400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
12GF Score

Get the complete analysis for CGON

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.96
Price